Chromogranin A: a novel susceptibility gene for essential hypertension.

Cellular and Molecular Life Sciences : CMLS
Bhavani S SahuNitish R Mahapatra

Abstract

Chromogranin A (CHGA) is ubiquitously expressed in secretory cells of the endocrine, neuroendocrine, and neuronal tissues. Although this protein has long been known as a marker for neuroendocrine tumors, its role in cardiovascular disease states including essential hypertension (EH) has only recently been recognized. It acts as a prohormone giving rise to bioactive peptides such as vasostatin-I (human CHGA(1-76)) and catestatin (human CHGA(352-372)) that exhibit several cardiovascular regulatory functions. CHGA is over-expressed but catestatin is diminished in EH. Moreover, genetic variants in the promoter, catestatin, and 3'-untranslated regions of the human CHGA gene alter autonomic activity and blood pressure. Consistent with these findings, targeted ablation of this gene causes severe arterial hypertension and ventricular hypertrophy in mice. Transgenic expression of the human CHGA gene or exogenous administration of catestatin restores blood pressure in these mice. Thus, the accumulated evidence establishes CHGA as a novel susceptibility gene for EH.

References

Aug 1, 1992·Neuroscience·H Winkler, R Fischer-Colbrie
Jan 1, 1992·Life Sciences·J E DimsdaleP Mills
Jan 1, 1991·Trends in Biochemical Sciences·W B HuttnerP Rosa
Aug 1, 1990·The Journal of Clinical Endocrinology and Metabolism·M A TakiyyuddinD T O'Connor
Jun 1, 1990·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·H J SteinerH Winkler
Jan 1, 1990·Circulation·M A TakiyyuddinD T O'Connor
Mar 1, 1990·Hypertension·M A TakiyyuddinD T O'Connor
Jul 1, 1995·Hypertension·M A TakiyyuddinF A Wright
Sep 1, 1994·Acta Physiologica Scandinavica·R H AngelettiK B Helle
Apr 1, 1996·British Journal of Cancer·A CortiA G Siccardi
Feb 7, 2001·The Journal of Biological Chemistry·K LugardonM H Metz-Boutigue
May 10, 2000·Blood Pressure·D T O'ConnorR J Parmer
May 23, 2000·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·M WeiergräberT Schneider
Sep 26, 2000·Molecular Genetics and Metabolism·D E Comings, J P MacMurray
Feb 13, 2001·British Journal of Clinical Pharmacology·K M O'Shaughnessy
Feb 24, 2001·Advances in Experimental Medicine and Biology·D Aunis, M H Metz-Boutigue
Feb 24, 2001·Advances in Experimental Medicine and Biology·J F BrekkeK B Helle
Mar 10, 2001·Cell·R P LiftonD S Geller
Mar 14, 2002·Regulatory Peptides·Johan F BrekkeKaren B Helle
Jul 9, 2002·Clinical Endocrinology·Bernini GiampaoloSalvetti Antonio
Nov 20, 2002·Annals of the New York Academy of Sciences·A CortiB Tota
Nov 20, 2002·Annals of the New York Academy of Sciences·Fangwen RaoDaniel T O'Connor
Mar 21, 2003·The New England Journal of Medicine·Laurent TaupenotDaniel T O'Connor
Jan 22, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Elisabetta FerreroAngelo Corti
Feb 3, 2005·Biological Reviews of the Cambridge Philosophical Society·Karen B Helle

❮ Previous
Next ❯

Citations

Aug 25, 2011·Endocrine Reviews·Alessandro BartolomucciStephen R J Salton
Nov 28, 2013·Cardiovascular Drugs and Therapy·John A Loudon
Dec 12, 2013·Biomarkers in Medicine·Jens P GoetzeJens F Rehfeld
Jun 12, 2010·Annales d'endocrinologie·M d'HerbomezUNKNOWN groupe des tumeurs endocrines (GTE France)
Sep 23, 2011·Autonomic Neuroscience : Basic & Clinical·Ahmed A RahmanPaul M Pilowsky
Nov 14, 2014·Journal of Human Hypertension·F Z MarquesF J Charchar
Dec 3, 2015·Journal of Cellular Physiology·Gaetano Santulli
Nov 13, 2019·Journal of Hypertension·Saiful A MirSucheta M Vaingankar
Aug 10, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lorenzo VeschiniElisabetta Ferrero
Dec 20, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yasmina BourebabaLynda Bourebaba
Oct 9, 2021·BMC Pregnancy and Childbirth·Michalina BralewskaAgata Sakowicz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.